Publication dates

All regions

Prostate Cancer Industry, October 2014 Market Reports from Top Publishers

You might be interested in: drug, cancer drug, cancer, more »


 
1-20 of about 5 800 reports for Prostate Cancer

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

Bavarian Nordic A/S (Symbol:BAVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Bavarian nordic develops its products using mva-bn and vf-tricom technology platforms. Its products find application in the treatment of diseases such as smallpox, prostate cancer, anthrax, breast cancer ...

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

Bio-Path Holdings, Inc. (Symbol:BPTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Its products are used in the treatment of lymphoma, chronic myelogenous leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndrome, breast cancer, colon cancer, prostate ...

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Blood transcriptome analysis and data mining. The company's diagnostic areas include colon cancer, lung cancer, prostate cancer and breast cancer. Its products are available in canada, malaysia, china ...

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Depletion and recovery technology for serum or plasma and other biological fluids. The company offers products for the treatment of colorectal cancer and prostate cancer. It holds for vascular permeability ...

InterGenetics Incorporated - Strategic SWOT Analysis Review

InterGenetics Incorporated - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Risk. The comapny also has a range of research pipeline of predictive tests for other cancers such as ovarian, colon, and prostate cancer. Intergenetics is headquartered in oklahoma, the us ...

Unigene Laboratories, Inc. (UGNE) - Financial and Strategic SWOT Analysis Review

Unigene Laboratories, Inc. (UGNE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... The clinical, research and development peptide programs of unigene cover therapeutic areas such as endometriosis, osteoarthritis, satiety and obesity, prostate cancer, osteoporosis, pain, site-directed bone ...

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Almero, acyline and mer-102. Its products find application in the treatment of diseases such as bone metastases, breast cancer, osteoporosis, prostate cancer and deep vein thrombosis. The company has ...

Endocyte, Inc. (ECYT) - Financial and Strategic SWOT Analysis Review

Endocyte, Inc. (ECYT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Are used to treat solid tumors; folcepri used in treatment of folate receptor positive tumors; ec1169 used to treat prostate cancer, ec0652 to treat prostate tumors; ec1669 used in the treatment ...

GenSpera, Inc. (GNSZ) - Financial and Strategic SWOT Analysis Review

GenSpera, Inc. (GNSZ) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... cancer. Genspera's technology platform supports the development of drugs targeted at different cancers, and other applications such as imaging. The company has patents for the development of tumor ...

MetaStat, Inc. (MTST) - Financial and Strategic SWOT Analysis Review

MetaStat, Inc. (MTST) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Of metastasis in adenocarcinoma of the lung. Metastat also offers menacalc prostate, a diagnostic for prostate cancer; and menabloc, a platform technology that develops therapies that can preemptively reduce ...

About 1 600 reports for Prostate Cancer

Download Unlimited Documents from Trusted Public Sources

General Medicine And Specialty Medicine Industry in Sweden

  • Prostate Cancer Imaging Trends after a Nationwide Effort to Disc...
  • July 2013
    8 pages
  • Prostate Cancer  

  • Sweden  

    United States  

View report >

2 Companies for Prostate Cancer

Read our Company Profiles

Johnson and Johnson

United States

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.